Background: Isoflavones are phytoestrogens present in natural sources, and they resemble estradiol in structure
Introduction
The Women's Health Initiative has recently forced practitioners to reconsider their options for the prevention of cardiovascular diseases (CVDs) in postmenopausal women (1) . The risk of CVDs increases after menopause, which may be related to substantial metabolic changes that occur as women transit from premenopause to postmenopause. In many women, some features of the metabolic syndrome (abdominal adiposity, insulin resistance, dyslipidemia, and hypertension) emerge with estrogen deficiency.
Furthermore, it is also known that concentration of blood homocysteine (Hcy) is an independent risk factor for CVD. Total homocysteine (tHcy) is higher in postmenopausal than that in premenopausal women (2).
Although hormonal replacement therapy (HRT) looks to decrease Hcy levels (3), this therapy also increases the risk of CVD and breast cancer (1) .
HRT helps improve the quality of life of menopausal women. However, due to its high cost and probable side-effects, alternative therapy is now seriously being sought for. And, isoflavones are now getting attention as an alternate medicine. These are phytoestrogens, i.e. plant compounds, whose phenolic ring is similar to 17β-estradiol and that can bind to the estrogen receptor with a decreased affinity (4). Results of several studies have shown the beneficial effects of isoflavones on the tHcy level (5, 6) , although others did not observe any changes (7) (8) (9) (10) (11) . In the case of lipid level, some studies reported favorable effect (12, 13) .
However, a study in Bangladesh revealed that the dietary formononetin, one specific type of phytoestrogens, had no advantageous effect in reducing CVD risks in menopausal women (10) .
Although soy-milk is now popular in Bangladesh and it is known that the postmenopausal women of our population do not get enough support due to our poor socioeconomic condition, illiteracy, ignorance, and inadequate healthcare system, and they are at risk of estrogen deficiency.
The consumption of soy products such as soymilk containing isoflavones might help reduce the risk factors of CVD in menopausal women. The aim of this study was to assess the effects of soy-milk on serum tHcy levels, glycemic and lipidemic status among Bangladeshi postmenopausal women.
Materials and Methods

Subjects
The study was conducted at the Department of Biomedical Research Group (BMRG), BIRDEM, Dhaka, Bangladesh, during March-October 2012. Thirty-six postmenopausal women participated in the study. The study included those who were: aged between > 50 years; postmenopausal without the menstrual cycle for at least the one year; non-user of HRT and had an intact uterus, and also willing to obey the protocol and agreed to sign the written informed consent. The study excluded those who were receiving any oral contraceptives or hormone replacement therapy within the last three months; those who had a menstrual period of <12 months before initiation of the study protocol; those with any chronic illness advised for hospitalization; and those who were unable to answer. The minimum sample -size required was calculated using the formula (14) (μ1 -μ2)2= f(α, P)σ2(1/n+1/n); where, μ1-μ2= 1;
significance level (α) = 0.05; power (P) = 0.09, which gives f(α, P)=10.5; σ= 1.0.
Study Design
This randomized, un-blinded, open-ended, crossover study lasted for 52 days. During the study period, the patients made four visits (before and after the intervention including the washout period). All the postmenopausal women were randomly divided into two groups: Group A and Group B.
The postmenopausal women of Group A received soy-milk and of Group B received conventional diet for three weeks and after the 10-day washout period, Group B received soy-milk, and group A received conventional diet for another three weeks (Fig 1) .
The soy-milk groups consumed 350 mL of soymilk twice a day; the milk contained ~30 mg of isoflavones. The number of isoflavones was calculated following the instructions of the Japan-Bangladesh
Cultural Exchange Association (15) . An amount of 350-mL soy-milk was prepared from the 100 g bean were measured on day 0 and again on day 21 after taking soy-milk and before and after day 31 and day 52 after the 10-day washout period. During this experiment, the subjects were requested not to take any kind of rich food and isoflavones-rich foods, such as mung, masoor dals, soybean, raw garlic, green bean, potatoes, sweet potatoes, nuts, chickpeas, wheat flour, grapefruit, dates, egg, and nut.
The blood samples were taken in a heparincontaining tube and centrifuged immediately. The serum was separated from the blood samples and stored at -30 0C for biochemical analysis.
Laboratory Analyses
Fasting serum glucose was analyzed using glucose oxidase method (Randox, UK). High- 
Ethical Aspects
Informed written consent was obtained from all the participants after a full explanation of nature, purpose, and procedures used for the study. Ethical approval was obtained from the ethics and research review committees of the Diabetic Association of Bangladesh.
Results
The mean age of the postmenopausal women was 50 ±5.16 years, and the mean duration of their menopause was 4 ±2.71 years. Of the patients, 94.4%
came from the urban area. The mean duration of years of education was 8 ±4 years. Nearly half (41.7%) of the menopausal women had a monthly family expenditure of Taka 5,000-10,000, and 27.4% were home-makers.
The mean body mass index (BMI) was 25.14 ±3.55 kg/m2. Of the menopausal women, 27.78% were at increased risk of overweight, and 44.44% were at the acceptable range of BMI (17) . Table 1 shows the baseline characteristics of the postmenopausal women.
The effects of soy-milk on glycemic, lipidemic and tHcy levels of the postmenopausal women are shown in Table 2 . No significant changes were found in tHcy, fasting blood glucose (FBG), serum triglycerides (TG), serum total cholesterol (TC), and serum LDL-C between and within the groups except on serum HDL-C.
In the soy-milk group, the level of serum HDL-C 
